When nerves lose the energy they need to function, it leads to numbness, pain, and loss of mobility for millions of Americans. New research is uncovering how risk factors like obesity, high blood pressure, and food insecurity disproportionately affect certain communities. As scientists work to refine treatments and explore promising therapies that include GLP-1 medications, early detection, dietary changes, and improved access to healthcare remain critical to stopping the progression of this condition.
Guest Information:
- Dr. Eva Feldman, Russell N. DeJong Professor of neurology, University of Michigan, director of the NeuroNetwork for Emerging Therapies, Michigan Medicine
- Evan Reynolds, assistant professor of epidemiology and biostatistics, Michigan State University College of Human Medicine
Leave a Reply